Mucopolysaccharidosis II Market Report

Global and Region Mucopolysaccharidosis II Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：167
  • REPORT CODE：GMM918431
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Mucopolysaccharidosis II market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Mucopolysaccharidosis IImarket, defines the market attractiveness level of Mucopolysaccharidosis II market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Mucopolysaccharidosis II industry, describes the types of Mucopolysaccharidosis II market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mucopolysaccharidosis II market and the development prospects and opportunities of Mucopolysaccharidosis II industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mucopolysaccharidosis II market in Chapter 13.

    By Player:

    • Laboratorios Del Dr Esteve SA

    • RegenxBio Inc

    • Alexion Pharmaceuticals, Inc

    • Sangamo BioSciences, Inc

    • ArmaGen Inc

    • AngioChem Inc

    • Bioasis Technologies Inc

    • Shire Plc

    • JCR Pharmaceuticals Co, Ltd

    • Green Cross Corporation

    • Inventiva

    By Type:

    • JR-141

    • EGT-301

    • DUOC-01

    • AGT-182

    • JR-032

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Research Center

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Mucopolysaccharidosis II Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Mucopolysaccharidosis II Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Mucopolysaccharidosis II Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Mucopolysaccharidosis II Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Mucopolysaccharidosis II Market Analysis and Outlook to 2022

    • 7.1 Global Mucopolysaccharidosis II Consumption (2017-2022)

    • 7.2 United States Mucopolysaccharidosis II Consumption (2017-2022)

    • 7.3 Europe Mucopolysaccharidosis II Consumption (2017-2022)

    • 7.4 China Mucopolysaccharidosis II Consumption (2017-2022)

    • 7.5 Japan Mucopolysaccharidosis II Consumption (2017-2022)

    • 7.6 India Mucopolysaccharidosis II Consumption (2017-2022)

    • 7.7 South Korea Mucopolysaccharidosis II Consumption (2017-2022)

    8 Region and Country-wise Mucopolysaccharidosis II Market Analysis and Outlook to 2028

    • 8.1 Global Mucopolysaccharidosis II Consumption Forecast (2022-2028)

    • 8.2 United States Mucopolysaccharidosis II Consumption Forecast (2022-2028)

    • 8.3 Europe Mucopolysaccharidosis II Consumption Forecast (2022-2028)

    • 8.4 China Mucopolysaccharidosis II Consumption Forecast (2022-2028)

    • 8.5 Japan Mucopolysaccharidosis II Consumption Forecast (2022-2028)

    • 8.6 India Mucopolysaccharidosis II Consumption Forecast (2022-2028)

    • 8.7 South Korea Mucopolysaccharidosis II Consumption Forecast (2022-2028)

    9 Global Mucopolysaccharidosis II Market Outlook by Types and Applications to 2022

    • 9.1 Global Mucopolysaccharidosis II Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global JR-141 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global EGT-301 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global DUOC-01 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global AGT-182 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global JR-032 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Mucopolysaccharidosis II Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Mucopolysaccharidosis II Market Outlook by Types and Applications to 2028

    • 10.1 Global Mucopolysaccharidosis II Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global JR-141 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global EGT-301 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global DUOC-01 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global AGT-182 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global JR-032 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Mucopolysaccharidosis II Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Mucopolysaccharidosis II Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Mucopolysaccharidosis II Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Mucopolysaccharidosis II Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Mucopolysaccharidosis II Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Mucopolysaccharidosis II Market Competitive Analysis

    • 14.1 Laboratorios Del Dr Esteve SA

      • 14.1.1 Laboratorios Del Dr Esteve SA Company Details

      • 14.1.2 Laboratorios Del Dr Esteve SA Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Laboratorios Del Dr Esteve SA Mucopolysaccharidosis II Product and Service

    • 14.2 RegenxBio Inc

      • 14.2.1 RegenxBio Inc Company Details

      • 14.2.2 RegenxBio Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 RegenxBio Inc Mucopolysaccharidosis II Product and Service

    • 14.3 Alexion Pharmaceuticals, Inc

      • 14.3.1 Alexion Pharmaceuticals, Inc Company Details

      • 14.3.2 Alexion Pharmaceuticals, Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Alexion Pharmaceuticals, Inc Mucopolysaccharidosis II Product and Service

    • 14.4 Sangamo BioSciences, Inc

      • 14.4.1 Sangamo BioSciences, Inc Company Details

      • 14.4.2 Sangamo BioSciences, Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sangamo BioSciences, Inc Mucopolysaccharidosis II Product and Service

    • 14.5 ArmaGen Inc

      • 14.5.1 ArmaGen Inc Company Details

      • 14.5.2 ArmaGen Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 ArmaGen Inc Mucopolysaccharidosis II Product and Service

    • 14.6 AngioChem Inc

      • 14.6.1 AngioChem Inc Company Details

      • 14.6.2 AngioChem Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AngioChem Inc Mucopolysaccharidosis II Product and Service

    • 14.7 Bioasis Technologies Inc

      • 14.7.1 Bioasis Technologies Inc Company Details

      • 14.7.2 Bioasis Technologies Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bioasis Technologies Inc Mucopolysaccharidosis II Product and Service

    • 14.8 Shire Plc

      • 14.8.1 Shire Plc Company Details

      • 14.8.2 Shire Plc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Shire Plc Mucopolysaccharidosis II Product and Service

    • 14.9 JCR Pharmaceuticals Co, Ltd

      • 14.9.1 JCR Pharmaceuticals Co, Ltd Company Details

      • 14.9.2 JCR Pharmaceuticals Co, Ltd Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 JCR Pharmaceuticals Co, Ltd Mucopolysaccharidosis II Product and Service

    • 14.10 Green Cross Corporation

      • 14.10.1 Green Cross Corporation Company Details

      • 14.10.2 Green Cross Corporation Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Green Cross Corporation Mucopolysaccharidosis II Product and Service

    • 14.11 Inventiva

      • 14.11.1 Inventiva Company Details

      • 14.11.2 Inventiva Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Inventiva Mucopolysaccharidosis II Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Mucopolysaccharidosis II

    • Figure Mucopolysaccharidosis II Picture

    • Table Global Mucopolysaccharidosis II Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mucopolysaccharidosis II Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Mucopolysaccharidosis II Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Mucopolysaccharidosis II Consumption by Country (2017-2022)

    • Figure United States Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)

    • Table Europe Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)

    • Figure China Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)

    • Figure Japan Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)

    • Figure India Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)

    • Figure South Korea Mucopolysaccharidosis II Consumption and Growth Rate (2017-2022)

    • Figure Global Mucopolysaccharidosis II Consumption Forecast by Country (2022-2028)

    • Figure United States Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Mucopolysaccharidosis II Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global JR-141 Consumption and Growth Rate (2017-2022)

    • Figure Global EGT-301 Consumption and Growth Rate (2017-2022)

    • Figure Global DUOC-01 Consumption and Growth Rate (2017-2022)

    • Figure Global AGT-182 Consumption and Growth Rate (2017-2022)

    • Figure Global JR-032 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Research Center Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global JR-141 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global EGT-301 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DUOC-01 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AGT-182 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global JR-032 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Mucopolysaccharidosis II Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Mucopolysaccharidosis II Export by Region (Top 5 Countries) (2017-2028)

    • Table Laboratorios Del Dr Esteve SA (Foundation Year, Company Profile and etc.)

    • Table Laboratorios Del Dr Esteve SA Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table Laboratorios Del Dr Esteve SA Mucopolysaccharidosis II Product and Service

    • Table RegenxBio Inc (Foundation Year, Company Profile and etc.)

    • Table RegenxBio Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table RegenxBio Inc Mucopolysaccharidosis II Product and Service

    • Table Alexion Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Alexion Pharmaceuticals, Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Pharmaceuticals, Inc Mucopolysaccharidosis II Product and Service

    • Table Sangamo BioSciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Sangamo BioSciences, Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo BioSciences, Inc Mucopolysaccharidosis II Product and Service

    • Table ArmaGen Inc (Foundation Year, Company Profile and etc.)

    • Table ArmaGen Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table ArmaGen Inc Mucopolysaccharidosis II Product and Service

    • Table AngioChem Inc (Foundation Year, Company Profile and etc.)

    • Table AngioChem Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table AngioChem Inc Mucopolysaccharidosis II Product and Service

    • Table Bioasis Technologies Inc (Foundation Year, Company Profile and etc.)

    • Table Bioasis Technologies Inc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioasis Technologies Inc Mucopolysaccharidosis II Product and Service

    • Table Shire Plc (Foundation Year, Company Profile and etc.)

    • Table Shire Plc Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Plc Mucopolysaccharidosis II Product and Service

    • Table JCR Pharmaceuticals Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table JCR Pharmaceuticals Co, Ltd Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table JCR Pharmaceuticals Co, Ltd Mucopolysaccharidosis II Product and Service

    • Table Green Cross Corporation (Foundation Year, Company Profile and etc.)

    • Table Green Cross Corporation Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table Green Cross Corporation Mucopolysaccharidosis II Product and Service

    • Table Inventiva (Foundation Year, Company Profile and etc.)

    • Table Inventiva Mucopolysaccharidosis II Sales, Price, Value and Gross Profit (2017-2022)

    • Table Inventiva Mucopolysaccharidosis II Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US